These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| New York | 13-1432060 | |
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
| Large accelerated filer þ | Accelerated filer o |
Non-accelerated filer
o
(Do not check if a smaller reporting company) |
Smaller reporting company o |
| March 31, | December 31, | |||||||
| 2010 | 2009 | |||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 89,818 | $ | 80,135 | ||||
|
Trade receivables
|
478,407 | 454,528 | ||||||
|
Allowance for doubtful accounts
|
(9,587 | ) | (10,263 | ) | ||||
|
Inventories: Raw materials
|
243,089 | 228,999 | ||||||
|
Work in process
|
10,432 | 9,173 | ||||||
|
Finished goods
|
193,391 | 206,805 | ||||||
|
|
||||||||
|
Total Inventories
|
446,912 | 444,977 | ||||||
|
Deferred income taxes
|
58,588 | 55,002 | ||||||
|
Prepaid expenses and other current assets
|
106,796 | 103,687 | ||||||
|
|
||||||||
|
Total Current Assets
|
1,170,934 | 1,128,066 | ||||||
|
|
||||||||
|
Property, plant and equipment, at cost
|
1,254,523 | 1,265,885 | ||||||
|
Accumulated depreciation
|
(764,764 | ) | (764,592 | ) | ||||
|
|
||||||||
|
|
489,759 | 501,293 | ||||||
|
|
||||||||
|
|
||||||||
|
Goodwill
|
665,582 | 665,582 | ||||||
|
Intangible assets, net
|
53,409 | 54,948 | ||||||
|
Deferred income taxes
|
131,779 | 129,720 | ||||||
|
Other assets
|
166,763 | 165,165 | ||||||
|
|
||||||||
|
Total Assets
|
$ | 2,678,226 | $ | 2,644,774 | ||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Bank borrowings and overdrafts and current portion of long-term debt
|
$ | 80,782 | $ | 76,780 | ||||
|
Accounts payable
|
154,451 | 161,027 | ||||||
|
Accrued payrolls and bonuses
|
39,185 | 49,022 | ||||||
|
Dividends payable
|
19,843 | 19,786 | ||||||
|
Deferred income taxes
|
595 | 585 | ||||||
|
Restructuring and other charges
|
20,599 | 18,914 | ||||||
|
Other current liabilities
|
159,887 | 158,340 | ||||||
|
|
||||||||
|
Total Current Liabilities
|
475,342 | 484,454 | ||||||
|
|
||||||||
|
|
||||||||
|
Other Liabilities:
|
||||||||
|
Long-term debt
|
934,076 | 934,749 | ||||||
|
Deferred gains
|
53,603 | 54,884 | ||||||
|
Retirement liabilities
|
241,256 | 240,950 | ||||||
|
Other liabilities
|
157,078 | 157,827 | ||||||
|
|
||||||||
|
Total Other Liabilities
|
1,386,013 | 1,388,410 | ||||||
|
|
||||||||
|
|
||||||||
|
Commitments and Contingencies (Note 13)
|
||||||||
|
|
||||||||
|
Shareholders Equity:
|
||||||||
|
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,761,840
shares as of March 31, 2010 and December 31, 2009; and outstanding
79,391,908 and 79,157,393 shares as of March 31, 2010 and December 31, 2009
|
14,470 | 14,470 | ||||||
|
Capital in excess of par value
|
110,583 | 110,374 | ||||||
|
Retained earnings
|
2,383,145 | 2,339,205 | ||||||
|
Accumulated other comprehensive loss
|
(279,972 | ) | (270,974 | ) | ||||
|
|
||||||||
|
|
2,228,226 | 2,193,075 | ||||||
|
|
||||||||
|
Treasury stock, at cost - 36,369,932 shares as of March 31, 2010 and 36,604,447
shares as of December 31, 2009
|
(1,414,920 | ) | (1,424,072 | ) | ||||
|
|
||||||||
|
Total Shareholders Equity
|
813,306 | 769,003 | ||||||
|
|
||||||||
|
Noncontrolling interest
|
3,565 | 2,907 | ||||||
|
|
||||||||
|
Total Shareholders Equity including noncontrolling interest
|
816,871 | 771,910 | ||||||
|
|
||||||||
|
Total Liabilities and Shareholders Equity
|
$ | 2,678,226 | $ | 2,644,774 | ||||
|
|
||||||||
2
| Three Months Ended March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Net sales
|
$ | 653,909 | $ | 559,630 | ||||
|
|
||||||||
|
|
||||||||
|
Cost of goods sold
|
383,702 | 337,565 | ||||||
|
Research and development expenses
|
52,631 | 47,331 | ||||||
|
Selling and administrative expenses
|
106,471 | 91,347 | ||||||
|
Amortization of intangibles
|
1,538 | 1,538 | ||||||
|
Restructuring and other charges
|
4,988 | | ||||||
|
Interest expense
|
12,736 | 19,781 | ||||||
|
Other (income) expense, net
|
2,762 | (1,162 | ) | |||||
|
|
||||||||
|
|
564,828 | 496,400 | ||||||
|
|
||||||||
|
Income before taxes on income
|
89,081 | 63,230 | ||||||
|
Taxes on income
|
25,292 | 16,033 | ||||||
|
|
||||||||
|
Net income
|
63,789 | 47,197 | ||||||
|
|
||||||||
|
Other comprehensive income:
|
||||||||
|
Foreign currency translation adjustments
|
(11,076 | ) | 24,041 | |||||
|
Accumulated gains (losses) on derivatives
qualifying as hedges
|
286 | 1,581 | ||||||
|
Pension and postretirement net liability
adjustment
|
1,792 | 1,824 | ||||||
|
|
||||||||
|
Comprehensive income
|
$ | 54,791 | $ | 74,643 | ||||
|
|
||||||||
|
|
||||||||
|
Net income per share basic
|
$ | 0.80 | $ | 0.60 | ||||
|
|
||||||||
|
Net income per share diluted
|
$ | 0.80 | $ | 0.60 | ||||
|
|
||||||||
|
Average number of shares outstanding basic
|
78,767 | 78,195 | ||||||
|
|
||||||||
|
Average number of shares outstanding diluted
|
79,692 | 78,747 | ||||||
|
|
||||||||
|
Dividends declared per share
|
$ | 0.25 | $ | 0.25 | ||||
3
| Three Months Ended March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 63,789 | $ | 47,197 | ||||
|
Adjustments to reconcile to net cash provided by operations:
|
||||||||
|
Depreciation and amortization
|
20,032 | 18,631 | ||||||
|
Deferred income taxes
|
(5,169 | ) | 5,985 | |||||
|
Gain on disposal of assets
|
(623 | ) | (809 | ) | ||||
|
Equity based compensation
|
5,461 | 4,759 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Current receivables
|
(29,292 | ) | (36,222 | ) | ||||
|
Inventories
|
(6,056 | ) | 12,803 | |||||
|
Current payables
|
(13,707 | ) | (57,574 | ) | ||||
|
Other assets
|
(10,041 | ) | (5,536 | ) | ||||
|
Other liabilities
|
7,998 | (3,602 | ) | |||||
|
|
||||||||
|
Net cash provided by (used in) operations
|
32,392 | (14,368 | ) | |||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property, plant and equipment
|
(12,950 | ) | (7,644 | ) | ||||
|
Purchase of investments
|
(1,856 | ) | (198 | ) | ||||
|
Termination of net investment hedge
|
| (11,916 | ) | |||||
|
Proceeds from disposal of assets
|
64 | 675 | ||||||
|
|
||||||||
|
Net cash used in investing activities
|
(14,742 | ) | (19,083 | ) | ||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Cash dividends paid to shareholders
|
(19,786 | ) | (39,338 | ) | ||||
|
Net change in bank borrowings and overdrafts
|
5,351 | (7,264 | ) | |||||
|
Proceeds from issuance of stock under stock-based
compensation plans
|
7,372 | 347 | ||||||
|
Purchase of treasury stock
|
| (1,967 | ) | |||||
|
|
||||||||
|
Net cash used in financing activities
|
(7,063 | ) | (48,222 | ) | ||||
|
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(904 | ) | (9,205 | ) | ||||
|
|
||||||||
|
Net change in cash and cash equivalents
|
9,683 | (90,878 | ) | |||||
|
Cash and cash equivalents at beginning of year
|
80,135 | 178,467 | ||||||
|
|
||||||||
|
Cash and cash equivalents at end of period
|
$ | 89,818 | $ | 87,589 | ||||
|
|
||||||||
|
|
||||||||
|
Interest paid
|
$ | 26,442 | $ | 37,985 | ||||
|
|
||||||||
|
Income taxes paid
|
$ | 12,164 | $ | 7,763 | ||||
4
| Three Months Ended March 31, | ||||||||
| (Shares in thousands) | 2010 | 2009 | ||||||
|
Basic
|
78,767 | 78,195 | ||||||
|
Assumed dilution under stock plans
|
925 | 552 | ||||||
|
|
||||||||
|
Diluted
|
79,692 | 78,747 | ||||||
|
|
||||||||
5
| Asset- | ||||||||||||
| Employee- | Related | |||||||||||
| Related | and Other | Total | ||||||||||
|
Balance December 31, 2009
|
$ | 18,914 | $ | | $ | 18,914 | ||||||
|
Additional charges
|
3,918 | 1,070 | 4,988 | |||||||||
|
Payments and other costs
|
(2,233 | ) | (1,070 | ) | (3,303 | ) | ||||||
|
|
||||||||||||
|
Balance March 31, 2010
|
$ | 20,599 | $ | | $ | 20,599 | ||||||
|
|
||||||||||||
| (DOLLARS IN THOUSANDS) | Amount | |||
|
Flavors
|
$ | 319,479 | ||
|
Fragrances
|
346,103 | |||
|
|
||||
|
Total
|
$ | 665,582 | ||
|
|
||||
| March 31, | December 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Gross carrying value
|
$ | 165,406 | $ | 165,406 | ||||
|
Accumulated amortization
|
(111,997 | ) | (110,458 | ) | ||||
|
|
||||||||
|
Total
|
$ | 53,409 | $ | 54,948 | ||||
|
|
||||||||
6
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2009
|
$ | (68,606 | ) | $ | (2,741 | ) | $ | (199,627 | ) | $ | (270,974 | ) | ||||
|
Change
|
(11,076 | ) | 286 | 1,792 | (8,998 | ) | ||||||||||
|
|
||||||||||||||||
|
Balance March 31, 2010
|
$ | (79,682 | ) | $ | (2,455 | ) | $ | (197,835 | ) | $ | (279,972 | ) | ||||
|
|
||||||||||||||||
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2008
|
$ | (149,846 | ) | $ | (3,832 | ) | $ | (171,427 | ) | $ | (325,105 | ) | ||||
|
Change
|
24,041 | 1,581 | 1,824 | 27,446 | ||||||||||||
|
|
||||||||||||||||
|
Balance March 31, 2009
|
$ | (125,805 | ) | $ | (2,251 | ) | $ | (169,603 | ) | $ | (297,659 | ) | ||||
|
|
||||||||||||||||
| (DOLLARS IN THOUSANDS) | Rate | Maturities | March 31, 2010 | December 31, 2009 | ||||||||||||
|
Bank borrowings and overdrafts
|
$ | 80,782 | $ | 76,780 | ||||||||||||
|
|
||||||||||||||||
|
Total current debt
|
80,782 | 76,780 | ||||||||||||||
|
|
||||||||||||||||
|
Senior notes - 2007
|
6.38 | % | 2017-27 | 500,000 | 500,000 | |||||||||||
|
Senior notes - 2006
|
6.06 | % | 2011-16 | 325,000 | 325,000 | |||||||||||
|
Bank borrowings
|
0.42 | % | 2012 | 75,178 | 75,166 | |||||||||||
|
Japanese Yen notes
|
2.81 | % | 2011 | 19,484 | 19,614 | |||||||||||
|
Other
|
9 | 16 | ||||||||||||||
|
Deferred realized gains on
interest rate swaps
|
14,405 | 14,953 | ||||||||||||||
|
|
||||||||||||||||
|
Total long-term debt
|
934,076 | 934,749 | ||||||||||||||
|
|
||||||||||||||||
|
Total debt
|
$ | 1,014,858 | $ | 1,011,529 | ||||||||||||
|
|
||||||||||||||||
7
| Weighted | ||||||||
| Average | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | Options/SSARs | Exercise Price | ||||||
|
Balance at December 31, 2009
|
2,228 | $ | 35.27 | |||||
|
Exercised
|
(391 | ) | $ | 34.04 | ||||
|
Cancelled
|
(6 | ) | $ | 43.13 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
1,831 | $ | 35.50 | |||||
|
|
||||||||
8
| Weighted | ||||||||
| Average Grant | ||||||||
| Date Fair | ||||||||
| Value Per | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | RSU | Share | ||||||
|
Balance at December 31, 2009
|
978 | $ | 37.42 | |||||
|
Cancelled
|
(2 | ) | $ | 41.16 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
976 | $ | 38.52 | |||||
|
|
||||||||
| Weighted | ||||||||
| Average Grant | ||||||||
| Date Fair | ||||||||
| Value Per | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | PRS | Share | ||||||
|
Balance at December 31, 2009
|
498 | $ | 20.28 | |||||
|
Granted
|
39 | $ | 22.90 | |||||
|
Cancelled
|
(4 | ) | $ | 15.24 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
533 | $ | 20.52 | |||||
|
|
||||||||
| Three Months Ended March 31, | ||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Restricted stock and RSUs
|
$ | 5,119 | $ | 4,088 | ||||
|
Stock options and SSARs
|
342 | 671 | ||||||
|
|
||||||||
|
Total equity compensation expense
|
$ | 5,461 | $ | 4,759 | ||||
|
|
||||||||
9
| Three Months Ended March 31, 2010 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
Net sales
|
$ | 300,169 | $ | 353,740 | | $ | 653,909 | |||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 61,577 | $ | 56,015 | $ | (13,013 | ) | 104,579 | ||||||||
|
|
||||||||||||||||
|
Interest expense
|
(12,736 | ) | ||||||||||||||
|
Other income (expense), net
|
(2,762 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 89,081 | ||||||||||||||
|
|
||||||||||||||||
| Three Months Ended March 31, 2009 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
Net sales
|
$ | 266,121 | $ | 293,509 | | $ | 559,630 | |||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 52,840 | $ | 36,791 | $ | (7,782 | ) | 81,849 | ||||||||
|
|
||||||||||||||||
|
Interest expense
|
(19,781 | ) | ||||||||||||||
|
Other income (expense), net
|
1,162 | |||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 63,230 | ||||||||||||||
|
|
||||||||||||||||
10
| U.S. Plans | Three Months Ended March 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Service cost for benefits earned
|
$ | 910 | $ | 1,180 | ||||
|
Interest cost on projected benefit obligation
|
5,990 | 5,985 | ||||||
|
Expected return on plan assets
|
(6,042 | ) | (6,042 | ) | ||||
|
Net amortization and deferrals
|
1,812 | 1,584 | ||||||
|
|
||||||||
|
Defined benefit plans
|
2,670 | 2,707 | ||||||
|
Defined contribution and other retirement plans
|
1,912 | 1,999 | ||||||
|
|
||||||||
|
Total pension expense
|
$ | 4,582 | $ | 4,706 | ||||
|
|
||||||||
| Non-U.S. Plans | Three Months Ended March 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Service cost for benefits earned
|
$ | 2,558 | $ | 1,983 | ||||
|
Interest cost on projected benefit obligation
|
8,411 | 7,136 | ||||||
|
Expected return on plan assets
|
(10,601 | ) | (9,351 | ) | ||||
|
Net amortization and deferrals
|
1,345 | 697 | ||||||
|
|
||||||||
|
Defined benefit plans
|
1,713 | 465 | ||||||
|
Defined contribution and other retirement plans
|
971 | 1,031 | ||||||
|
|
||||||||
|
Total pension expense
|
$ | 2,684 | $ | 1,496 | ||||
|
|
||||||||
| Three Months Ended March 31, | ||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Service cost for benefits earned
|
$ | 410 | $ | 441 | ||||
|
Interest on benefit obligation
|
1,643 | 1,556 | ||||||
|
Net amortization and deferrals
|
(489 | ) | (565 | ) | ||||
|
|
||||||||
|
Total postretirement benefit expense
|
$ | 1,564 | $ | 1,432 | ||||
|
|
||||||||
11
| | Level 1-Quoted prices for identical instruments in active markets. | ||
| | Level 2-Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. | ||
| | Level 3-Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable . |
12
| March 31, 2010 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total Fair | ||||||||||
| Instruments | Instruments | Value | ||||||||||
|
Derivative assets (a)
|
||||||||||||
|
Foreign currency contracts
|
$ | | $ | 0.9 | $ | 0.9 | ||||||
|
Interest rate swap
|
$ | 0.2 | $ | | $ | 0.2 | ||||||
|
|
||||||||||||
|
|
$ | 0.2 | $ | 0.9 | $ | 1.1 | ||||||
|
|
||||||||||||
|
Derivative liabilities (b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 4.0 | $ | 0.4 | $ | 4.4 | ||||||
| December 31, 2009 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total Fair | ||||||||||
| Instruments | Instruments | Value | ||||||||||
|
Derivative assets (a)
|
||||||||||||
|
Foreign currency contracts
|
$ | | $ | 0.2 | $ | 0.2 | ||||||
|
Interest rate swap
|
$ | 0.2 | $ | | $ | 0.2 | ||||||
|
|
||||||||||||
|
|
$ | 0.2 | $ | 0.2 | $ | 0.4 | ||||||
|
|
||||||||||||
|
Derivative liabilities (b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 4.5 | $ | 0.9 | $ | 5.4 | ||||||
13
| Amount of Gain or | ||||||||||||
| (Loss) Recognized in | ||||||||||||
| Income on Derivative | Location of | |||||||||||
| Gain or (Loss) | ||||||||||||
| For the Three Months Ended | Recognized in | |||||||||||
| Derivatives Not Designated as | March 31, | Income on | ||||||||||
| Hedging Instruments | 2010 | 2009 | Derivative | |||||||||
|
Foreign currency contract
|
$ | (2.2 | ) | $ | 3.0 |
Other (income)
expense, net |
||||||
14
| Amount of Gain or | ||||||||||||||||||||||
| Amount of Gain or | Location of | (Loss) Reclassifed | ||||||||||||||||||||
| (Loss) Recognized in | Gain or (Loss) | from AOCI into | ||||||||||||||||||||
| OCI on Derivative | Reclassifed | Income (Effective | ||||||||||||||||||||
| (Effective Portion) | from AOCI | Portion) | ||||||||||||||||||||
| For the Three Months | into Income | For the Three Months | ||||||||||||||||||||
| Derivatives in Cash Flow | Ended March 31, | (Effective | Ended March 31, | |||||||||||||||||||
| Hedging Relationships (*) | 2010 | 2009 | Portion) | 2010 | 2009 | |||||||||||||||||
|
Derivatives in Cash Flow Hedging Relationships:
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
Cross currency swap (1)
|
$ | 0.3 | $ | 1.6 |
Other (income)
expense, net |
$ | (0.3 | ) | $ | (0.2 | ) | |||||||||||
|
|
||||||||||||||||||||||
|
Derivatives in Net Investment Hedging
Relationships:
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
Forward currency contract (2)
|
$ | 0.6 | $ | | N/A | N/A | | |||||||||||||||
|
Total
|
$ | 0.9 | $ | 1.6 | $ | (0.3 | ) | $ | (0.2 | ) | ||||||||||||
| (1) | Ten year swap executed in 2003. | |
| (2) | Contract matured during the three months ended March 31, 2010. | |
| (*) | No ineffectiveness was experienced in the above noted cash flow hedge during the three months ended March 31, 2010 and March 31, 2009. The ineffective portion of the net investment hedge was not material during the three months ended March 31, 2010 and March 31, 2009. |
15
16
| | created for the exclusive use by a specific customer; | ||
| | sold in powder or liquid form, in amounts ranging from a few pounds to several tons depending on the nature of the end product in which they are used; | ||
| | a small percentage of the volume and cost of the end product sold to the consumer; and | ||
| | a major factor in directing consumer preference for consumer packaged goods. |
17
18
| % Change in Sales-First Quarter 2010 vs First Quarter 2009 | ||||||||||||||||||||||||||
| Fine & | ||||||||||||||||||||||||||
| Beauty Care | Functional | Ingredients | Total Frag. | Flavors | Total | |||||||||||||||||||||
|
North America
|
Reported | 24 | % | -2 | % | 22 | % | 12 | % | -1 | % | 5 | % | |||||||||||||
|
EAME
|
Reported | 36 | % | 12 | % | 34 | % | 25 | % | 18 | % | 22 | % | |||||||||||||
|
|
Local Currency | 31 | % | 8 | % | 29 | % | 21 | % | 12 | % | 17 | % | |||||||||||||
|
Latin America
|
Reported | 38 | % | 6 | % | 10 | % | 17 | % | 13 | % | 16 | % | |||||||||||||
|
|
Local Currency | 31 | % | 5 | % | 9 | % | 14 | % | 6 | % | 11 | % | |||||||||||||
|
Greater Asia
|
Reported | 20 | % | 33 | % | 10 | % | 25 | % | 21 | % | 23 | % | |||||||||||||
|
|
Local Currency | 19 | % | 31 | % | 9 | % | 23 | % | 14 | % | 17 | % | |||||||||||||
|
Total
|
Reported | 31 | % | 12 | % | 24 | % | 21 | % | 13 | % | 17 | % | |||||||||||||
|
|
Local Currency | 28 | % | 10 | % | 21 | % | 18 | % | 8 | % | 13 | % | |||||||||||||
| § | North America Fine & Beauty sales growth was driven primarily by new wins and re-stocking, and weak year ago comparison levels. The strong performance in Ingredients reflects broad-based volume gains and weak market conditions last year. Functional fragrance sales were down 2% as strong fabric care growth was not enough to offset home care volume losses. Flavors business declined slightly in line with the overall market. | |
| § | EAME showed strong sales gains across all categories, led by net new wins and demand recovery in Fine Fragrance and Ingredients as well as new wins in developing markets for Flavors, notably within the Beverage and Confectionery categories. Customer re-stocking also supported growth across most categories. | |
| § | Latin America sales performance was driven by a strong recovery in Fine & Beauty, new wins in Functional Fragrance and new wins and volume recovery in Confectionery and Savory for Flavors that more than offset the effects of non-strategic business lost last year. | |
| § | Greater Asia delivered double-digit LC sales growth in all categories, except Ingredients, whose growth was 9%. Fine & Beauty gains were driven by new wins in Hair Care and Toiletries as well as demand recovery for Fine Fragrance off a weak prior year base. We continue to experience strong growth in Fabric and Personal Wash within Functional Fragrances while Flavor sales growth was driven by new product introductions in Savory and Beverage. |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Cost of goods sold
|
58.7 | % | 60.3 | % | ||||
|
Research and development expenses
|
8.0 | % | 8.5 | % | ||||
|
Selling and administrative expenses
|
16.3 | % | 16.3 | % | ||||
19
| Restructuring | ||||
| Charges | ||||
| (In Thousands) | 2010 | |||
|
Fragrances
|
$ | 4,988 | ||
|
|
||||
|
Total
|
$ | 4,988 | ||
|
|
||||
20
21
| 12 Months Ended March 31, | ||||||||
| (In Millions) | 2010 | 2009 | ||||||
|
Net income
|
$ | 212.1 | $ | 220.9 | ||||
|
Interest expense
|
54.7 | 75.6 | ||||||
|
Income taxes
|
90.3 | 47.1 | ||||||
|
Depreciation
|
73.7 | 68.9 | ||||||
|
Amortization
|
6.2 | 6.2 | ||||||
|
Specified items
(1)
|
29.6 | 19.3 | ||||||
|
Adjusted EBITDA
|
$ | 466.6 | $ | 438.0 | ||||
| (1) | Principally restructuring and certain employee separation costs. |
| March 31, | ||||||||
| (In Millions) | 2010 | 2009 | ||||||
|
Total debt
|
$ | 1,014.9 | $ | 1,215.4 | ||||
|
Adjustments:
|
||||||||
|
Deferred gain on interest rate swaps
|
(14.4 | ) | (16.4 | ) | ||||
|
Cash and cash equivalents
|
(89.8 | ) | (87.6 | ) | ||||
|
Net debt
|
$ | 910.7 | $ | 1,111.4 | ||||
22
23
24
25
26
| Total | Total Number of | Maximum Number | ||||||||||||||
| Number of | Shares Purchased | of Shares That May | ||||||||||||||
| Shares | Average | as Part of Publicly | Yet Be Purchased | |||||||||||||
| Purchased | Price Paid | Announced | Under the Program | |||||||||||||
| (1) | per Share | Program (1) | (1) | |||||||||||||
|
January 1 31, 2010
|
| | | 1,949,065 | ||||||||||||
|
February 1 28, 2010
|
| | | 1,949,065 | ||||||||||||
|
March 1 31, 2010
|
| | | 1,949,065 | ||||||||||||
|
Total shares purchased
|
| | | |||||||||||||
| (1) | In July 2007 our Board of Directors authorized a stock repurchase plan (the 2007 Share Repurchase Plan) to repurchase up to 15% (which represents an aggregate 13,350,000 shares) or $750 million worth of our outstanding common stock, whichever is less. As of March 31, 2010, we are subject to the 15% limitation and as such, we still have the ability to repurchase approximately 2 million shares. There is no stated expiration for the July 2007 share repurchase program. |
27
|
10.1
|
International Flavors & Fragrances Inc. 2010 Named Executive Officer Compensation Matters | |
|
|
||
|
31.1
|
Certification of Douglas D. Tough pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
|
||
|
31.2
|
Certification of Kevin C. Berryman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
|
||
|
32
|
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002. |
|
Dated: May 6, 2010
|
By: | /s/ Douglas D. Tough | ||
|
|
||||
| Douglas D. Tough | ||||
| Chairman of the Board and Chief Executive Officer | ||||
|
|
||||
|
Dated: May 6, 2010
|
By: | /s/ Kevin C. Berryman | ||
|
|
||||
| Kevin C. Berryman | ||||
| Executive Vice President and Chief Financial Officer | ||||
28
| Number | Description | |
|
|
||
|
10.1
|
International Flavors & Fragrances Inc. 2010 Named Executive Officer Compensation Matters | |
|
|
||
|
31.1
|
Certification of Douglas D. Tough pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
|
||
|
31.2
|
Certification of Kevin C. Berryman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
|
||
|
32
|
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002. |
29
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Estée Lauder Companies Inc. | EL |
| L Brands, Inc. | LB |
| Revlon, Inc. | REV |
Suppliers
| Supplier name | Ticker |
|---|---|
| Stepan Company | SCL |
| Sensient Technologies Corporation | SXT |
| Tredegar Corporation | TG |
| Flotek Industries, Inc. | FTK |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|